Table 2 Demographic characteristics, baseline generic prognostic baseline factors and baseline illness perceptions N = 251
|  | Lost to follow-up N = 14 | |
|---|---|---|
Age (SD) | 46.1 (13.8) | 41.3 (13.7) |
Gender ♀ (%) | 68.9 | 85.7 |
Body pain locations (%) | ||
 Head | 4.7 | 0.0 |
 Neck, shoulder, upper spins | 35.6 | 50.0 |
 Elbow, pols, hand | 3.8 | 7.1 |
 Lower back | 16.5 | 21.4 |
 Hip, knee | 14.8 | 0.0 |
 Ankle, foot | 5.5 | 7.2 |
 Multiple locations | 19.1 | 14.3 |
Musculoskeletal pain conditions (%) N = 192 | ||
 Joint conditions (i.e. rheumatoid arthritis | 2.1 | 0 |
 Osteoarthritis | 18.2 | 25.0 |
 Bone conditions (i.e. osteoporosis) | 3.1 | 0 |
 Musculoskeletal injuries (e.g. low back pain) | 64.1 | 70.0 |
 Regional and widespread pain disorders | 12.5 | 0 |
 Multisystem inflammatory diseases | 0 | 0 |
Pain intensity 0–10 (SD) | 6.3 (2.8) | 7.0 (2.4) |
Physical functioning (0–10) | 6.3 (2.2) | 6.2 (1.5) |
Pain duration % | ||
 < 7 weeks | 32.3 | 28.6 |
 7–13 weeks | 20.7 | 7.1 |
 > 13 weeks | 47.0 | 64.3 |
 > 2 pain sites (%) | 19.1 | 14.3 |
4DSQ risk of (%) | ||
 Somatization (%) | ||
  Low (0–10) | 59.8 | 50.0 |
  Medium [11–20] | 29.5 | 41.7 |
  High [21–32] | 10.7 | 8.3 |
 Distress (%) | ||
  Low (0–10) | 61.2 | 72.7 |
  Medium [11–20] | 22.7 | 9.1 |
  High [21–32] | 16.1 | 18.2 |
 Anxiety (%) | ||
  Low (0–3) | 75.4 | 69.2 |
  Medium [4–9] | 10.3 | 23.1 |
  High [10–24] | 14.3 | 7.7 |
 Depression (%) | ||
  Low (0–2) | 81.5 | 61.5 |
  Medium [3–5] | 7.3 | 23.1 |
  High [6–12] | 11.3 | 15.4 |
Baseline illness perceptions 0–10 (SD) | ||
 Consequences | 5.4 (2.9) | 5.1 (3.8) |
 Timeline | 5.1 (3.2) | 4.1 (3.0) |
 Personal Controla | 4.8 (2.6) | 4.4 (3.7) |
 Treatment Controla | 7.3 (2.1) | 6.1 (3.3) |
 Identity | 5.8 (2.3) | 5.9 (3.2) |
 Concern | 4.1 (3.6) | 5.1 (3.7) |
 Coherencea | 6.8 (2.5) | 6.0 (3.6) |
 Emotional Response | 4.5 (3.1) | 4.9 (3.9) |